ZA89829B - Crystalline b-lactam solvate - Google Patents

Crystalline b-lactam solvate

Info

Publication number
ZA89829B
ZA89829B ZA89829A ZA89829A ZA89829B ZA 89829 B ZA89829 B ZA 89829B ZA 89829 A ZA89829 A ZA 89829A ZA 89829 A ZA89829 A ZA 89829A ZA 89829 B ZA89829 B ZA 89829B
Authority
ZA
South Africa
Prior art keywords
lactam
solvate
crystalline
lactam solvate
Prior art date
Application number
ZA89829A
Other languages
English (en)
Inventor
Byron Wade Daugherty
Wade Daugherty Byron
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA89829B publication Critical patent/ZA89829B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
ZA89829A 1988-02-05 1989-02-02 Crystalline b-lactam solvate ZA89829B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15277788A 1988-02-05 1988-02-05

Publications (1)

Publication Number Publication Date
ZA89829B true ZA89829B (en) 1990-10-31

Family

ID=22544405

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89829A ZA89829B (en) 1988-02-05 1989-02-02 Crystalline b-lactam solvate

Country Status (12)

Country Link
EP (1) EP0327364A1 (xx)
JP (1) JPH021489A (xx)
KR (1) KR890012960A (xx)
CN (1) CN1034929A (xx)
AU (1) AU615026B2 (xx)
DK (1) DK49989A (xx)
HU (1) HU204271B (xx)
IL (1) IL89150A0 (xx)
NZ (1) NZ227842A (xx)
PT (1) PT89612A (xx)
SU (1) SU1750429A3 (xx)
ZA (1) ZA89829B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
AU1234999A (en) * 1997-11-10 1999-05-31 Gist-Brocades B.V. Crystallization of beta-lactam compounds
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US7361785B2 (en) * 2002-11-05 2008-04-22 Lead Chemical Co., Ltd. Compound protecting against ultraviolet rays
US8629178B2 (en) * 2009-11-03 2014-01-14 Li Liu Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
ZA877398B (en) * 1986-10-03 1989-05-30 Lilly Co Eli 7-((meta-substituted)phenylglycine)1-carba-1-dethiacephalosporins

Also Published As

Publication number Publication date
HU204271B (en) 1991-12-30
AU615026B2 (en) 1991-09-19
SU1750429A3 (ru) 1992-07-23
DK49989D0 (da) 1989-02-03
IL89150A0 (en) 1989-09-10
KR890012960A (ko) 1989-09-20
NZ227842A (en) 1990-12-21
CN1034929A (zh) 1989-08-23
PT89612A (pt) 1989-10-04
JPH021489A (ja) 1990-01-05
DK49989A (da) 1989-08-07
HUT49616A (en) 1989-10-30
EP0327364A1 (en) 1989-08-09
AU2961989A (en) 1989-08-10

Similar Documents

Publication Publication Date Title
EP0420608A3 (en) Cephalosporin derivatives
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
EP0297383A3 (en) Hydroxyethyl-azolyl derivatives
ZA89829B (en) Crystalline b-lactam solvate
EP0327270A3 (en) Macrolide compounds
IL96048A0 (en) Crystalline polyimidesiloxanes
IL88134A0 (en) Substituted azacyclohexyl derivatives
EP0351863A3 (en) Exterior structure for cabinet
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
EP0322164A3 (en) Ethanolamie derivatives
GB8821160D0 (en) Antibiotic ge 2270
ZA887966B (en) Substituted azacyclohexyl derivatives
IL90695A0 (en) Substituted azacyclohexyl derivatives
GB2200910B (en) Thiopilocarpine derivatives
GB8704236D0 (en) Anthracycline-oestrone derivatives
GB8700016D0 (en) Quinolizinone derivatives
IE882472L (en) Antibiotic a80577
IE882497L (en) Cephalosporin derivative
GB8721697D0 (en) Azetidine derivatives
GB8724649D0 (en) Antibiotic compounds
ZM8587A1 (en) Antibiotic compounds
GB8826747D0 (en) Azetidine derivatives
GB2211840B (en) Indenofuran derivatives
IE890351L (en) Crystalline solvate of a 1-carbacephalosporin